Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Free Cash Flow (2020 - 2025)

Celularity (CELU) has disclosed Free Cash Flow for 6 consecutive years, with -$4.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow fell 2054.92% to -$4.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$6.6 million, a 48.81% increase, with the full-year FY2024 number at -$6.6 million, up 83.48% from a year prior.
  • Free Cash Flow was -$4.2 million for Q3 2025 at Celularity, down from -$999000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $1.5 million in Q4 2024 to a low of -$37.8 million in Q3 2022.
  • A 5-year average of -$16.0 million and a median of -$11.8 million in 2023 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: plummeted 7993.73% in 2021, then surged 130.54% in 2024.
  • Celularity's Free Cash Flow stood at -$31.4 million in 2021, then rose by 6.88% to -$29.3 million in 2022, then skyrocketed by 83.18% to -$4.9 million in 2023, then soared by 130.54% to $1.5 million in 2024, then crashed by 376.71% to -$4.2 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Free Cash Flow are -$4.2 million (Q3 2025), -$999000.0 (Q2 2025), and -$3.0 million (Q1 2025).